Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 4:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2665–2688 of 2,690 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Normal saline solution Clear all

Conditions: Papulopustular Rosacea
Interventions: Cromolyn Sodium, Normal Saline; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Diego, California

Conditions: Acute Respiratory Distress Syndrome (ARDS)
Interventions: Budesonide, Placebo, Formoterol; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 5
States / cities: Tucson, Arizona • Stanford, California • Jacksonville, Florida + 2 more

Conditions: Glycogen Storage Disease Type IA
Interventions: DTX401, Placebo, Oral prednisolone, Placebo for oral prednisolone; Genetic · Other · Drug
Lead sponsor: Ultragenyx Pharmaceutical Inc; Industry
Eligibility: 8 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 9
States / cities: Orange, California • Aurora, Colorado • Farmington, Connecticut + 6 more

Conditions: Thrombosis
Interventions: Heparin sulfate infusion at 10 units/kg/hour, Placebo infusion; Drug
Lead sponsor: Stanford University; Other
Eligibility: 1 Day to 1 Year
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Stanford, California

Conditions: Lung Biopsy
Interventions: ABPI, BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug; Other · Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 454 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 2
States / cities: Harrison, New York • New York, New York

Conditions: Pain, Postoperative
Interventions: Combined Bupivacaine and Exparel, Normal Saline (NS); Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Fibroid Uterus
Interventions: Bupivacaine, Bupivacaine liposome, normal saline; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Parkinson's Disease
Interventions: piclozotan, 0.9% sodium chloride (normal saline); Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 5
States / cities: Fountain Valley, California • Tampa, Florida • Atlanta, Georgia + 2 more

Conditions: Respiratory Syncytial Virus
Interventions: mRNA-1345, Placebo; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 10,994 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 109
States / cities: Birmingham, Alabama • Guntersville, Alabama • Huntsville, Alabama + 93 more

Conditions: Influenza
Interventions: Cold-adapted live attenuated influenza virus vaccine, trivalent, Placebo, Trivalent inactivated influenza vaccine; Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 49 Years
Enrollment: 2,349 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 6
States / cities: Ann Arbor, Michigan • Kalamazoo, Michigan • Livonia, Michigan + 2 more

Conditions: Atelectasis
Interventions: Normal saline:, Hypertonic Saline, Dornase alpha; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Head and Neck Cancer, Surgery--Complications, Graft Failure
Interventions: Tumescence During STSG Harvest; Procedure
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Infections
Interventions: Normal saline pressurized irrigation, sub-q gentamicin; Procedure · Drug
Lead sponsor: Dallas VA Medical Center; Federal
Eligibility: 18 Years to 95 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Intracranial Hemorrhages
Interventions: Phenobarbital, Saline; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Female only
Enrollment: 610 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1993 – 1997
U.S. locations: 11
States / cities: Palo Alto, California • New Haven, Connecticut • Washington D.C., District of Columbia + 8 more

Conditions: Non Small Cell Lung Cancer
Interventions: Healthy Donor Fecal Microbiota Transplant (hdFMT), Pembrolizumab; Drug
Lead sponsor: Diwakar Davar; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2036
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Spine Surgery
Interventions: Dexmedetomidine, Normal Saline; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Seattle, Washington

Conditions: Abdominal Pain
Interventions: Morphine Sulfate; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 1 Year to 18 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Infertility
Interventions: Lipiodol UF, Saline; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: COVID-19, Healthy
Interventions: Optate, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Femoral Neck Fractures
Interventions: Tranexamic Acid, Placebo (saline); Drug
Lead sponsor: UConn Health; Other
Eligibility: 55 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Farmington, Connecticut • Hartford, Connecticut

Conditions: Labor Pain
Interventions: Intracutaneous injections; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Lumbar Radiculopathy
Interventions: Corticosteroid injection; Drug
Lead sponsor: Lahey Clinic; Other
Eligibility: 30 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: ST-Elevation Myocardial Infarction
Interventions: eptifibatide, normal saline; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: Ormond Beach, Florida • Rochester, Michigan • Mansfield, Ohio

Conditions: Insulin Sensitivity
Interventions: Glucagon Infusion, Saline; Drug · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: San Antonio, Texas

Search by objective public record fields.

An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema

LIPS-B: Lung Injury Prevention Study With Budesonide and Beta

A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)

Heparin and the Reduction of Thrombosis (HART) Trial

Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures

Long-acting Local Vaginal Cuff Anesthesia Following Hysterectomy

Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study

FLU-VACS Comparative Study in Adults

Dornase Alpha Versus Hypertonic Saline for Lung Atelectasis in Non-Cystic Fibrosis Patients

Tumescence in HNC Skin Graft Reconstruction

Effectiveness for Interventions to Minimize Surgical Site Infections

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC

Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery

The Effect of Pain Medication in Children With Acute Abdominal Pain and Its Implication Over the Surgeon's Decision

Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)

A Nasal Treatment for COVID-19

Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty

Intracutaneous Sterile Water Injections

Preoperative Corticosteroid Epidural Injection and Lumbar Decompression Surgery Outcomes

A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks

Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism